Stock HLN HALEON PLC
Add to a list
To use this feature you must be a member
Log inSign up

Company Haleon plc Nyse

Equities

HLN

US4055521003

Pharmaceuticals

Market Closed - Nyse
Other stock markets
 16:00:02 2024-05-17 EDT 		5-day change 1st Jan Change
8.51 USD +1.67% Intraday chart for Haleon plc +3.28% +3.40%
05-17 UK's FTSE 100 Closes Lower Amid Inflation Focus MT
05-17 GSK Sells Remaining Stake in Haleon for $1.58 Billion MT

Business Summary

Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows:

- oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.;

- Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.;

- medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.;

- respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.;

- vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc.

Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).

Number of employees: 25,408

Sales per Business

GBP in Million2022Weight2023Weight Delta
Oral Health
27.7 %
2,957 27.2 % 3,136 27.7 % +6.05%
Pain Relief
23.5 %
2,551 23.5 % 2,652 23.5 % +3.96%
Digestive Health and Other
18.9 %
2,096 19.3 % 2,138 18.9 % +2.00%
Respiratory Health
15.4 %
1,579 14.5 % 1,736 15.4 % +9.94%
Vitamins, Minerals and Supplements
14.5 %
1,675 15.4 % 1,640 14.5 % -2.09%

Sales per region

GBP in Million2022Weight2023Weight Delta
EMEA and Latin America
40.2 %
4,270 39.3 % 4,545 40.2 % +6.44%
North America
37.1 %
4,116 37.9 % 4,195 37.1 % +1.92%
APAC
22.7 %
2,472 22.8 % 2,562 22.7 % +3.64%

Managers

Managers TitleAgeSince
Brian McNamara CEO
 Chief Executive Officer 57 21-07-21
Tobias Hestler DFI
 Director of Finance/CFO 52 21-11-30
Franck Riot CTO
 Chief Tech/Sci/R&D Officer - 21-12-15
Sonya Ghobrial IRC
 Investor Relations Contact - -
Tamara Rogers SAM
 Sales & Marketing - 21-12-15
Lisa Paley PRN
 Corporate Officer/Principal - -
Keith Choy PRN
 Corporate Officer/Principal - -
Filippo Lanzi PRN
 Corporate Officer/Principal - -
Mairéad Nayager HRO
 Human Resources Officer - 22-02-28
Bjarne Tellmann LAW
 General Counsel 57 21-12-15

Members of the board

Members of the board TitleAgeSince
Bryan Supran BRD
 Director/Board Member - 22-07-17
Dame Cox BRD
 Director/Board Member 64 22-07-17
Tracy Clarke BRD
 Director/Board Member 57 22-07-17
Vindi Banga BRD
 Director/Board Member 69 22-07-17
Deirdre Mahlan BRD
 Director/Board Member 61 22-07-17
David Lewis CHM
 Chairman 59 22-05-22
David Denton BRD
 Director/Board Member 59 23-02-28
Tobias Hestler DFI
 Director of Finance/CFO 52 21-11-30
Brian McNamara CEO
 Chief Executive Officer 57 21-07-21
Asmita Dubey BRD
 Director/Board Member - 22-07-17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 9,132,301,104 7,075,906,839 ( 77.48 %) 0 77.48 %

Shareholders

NameEquities%Valuation
PFIZER, INC.
32.36 %
2,955,063,626 32.36 % 12 562 M $
GSK PLC
4.219 %
385,320,110 4.219 % 1 638 M $
Dodge & Cox
2.532 %
231,253,000 2.532 % 983 M $
The Vanguard Group, Inc.
2.405 %
219,663,000 2.405 % 934 M $
Norges Bank Investment Management
1.621 %
148,004,000 1.621 % 629 M $
MFS International (UK) Ltd.
1.379 %
125,915,466 1.379 % 535 M $
GIC Pte Ltd. (Investment Management)
1.045 %
95,442,000 1.045 % 406 M $
BlackRock Fund Advisors
1.009 %
92,189,000 1.009 % 392 M $
BlackRock Advisors (UK) Ltd.
0.9963 %
90,981,000 0.9963 % 387 M $
BlackRock Investment Management (UK) Ltd.
0.9364 %
85,518,000 0.9364 % 364 M $
NameEquities%Valuation
Dodge & Cox
3.875 %
176,953,251 3.875 % 1 486 M $
Fidelity Management & Research Co. LLC
1.835 %
83,806,041 1.835 % 704 M $
ClearBridge Investments LLC
0.8420 %
38,446,978 0.8420 % 323 M $
Fisher Asset Management LLC
0.3148 %
14,376,303 0.3148 % 121 M $
Wellington Management Co. LLP
0.2933 %
13,392,179 0.2933 % 112 M $
Citadel Securities GP LLC
0.2881 %
13,156,009 0.2881 % 111 M $
AllianceBernstein LP
0.2360 %
10,774,072 0.2360 % 91 M $
Merrill Lynch International
0.2319 %
10,590,597 0.2319 % 89 M $
RBC Private Counsel (USA), Inc.
0.1963 %
8,961,261 0.1963 % 75 M $
Aristotle Capital Management LLC
0.1946 %
8,887,558 0.1946 % 75 M $

Company contact information

Haleon Plc

The Heights Building 5, 1st Floor

KT13 0NY, Weybridge

+44 1932 822000

http://www.haleon.com
address Haleon plc(HLN)

Group companies

NameCategory and Sector
GlaxoSmithKline Consumer Pvt Ltd.
Logo GlaxoSmithKline Consumer Pvt Ltd.

GlaxoSmithKline Consumer Pvt Ltd.

Pharmaceuticals: MajorHealth Technology

Part of GSK Plc, GlaxoSmithKline Consumer Pvt Ltd. is an Indian company that develops, manufactures, and distributes vaccines and other pharmaceutical products. The company is based in Patiala, India and was founded in 2014.

Pharmaceuticals: Major
Haleon UK Trading Services Ltd.
Logo Haleon UK Trading Services Ltd.

Haleon UK Trading Services Ltd.

Drugstore ChainsRetail Trade

Part of Haleon Uk Holdings (No. 3) Ltd., Haleon UK Trading Services Ltd. is a wholesaler of pharmaceutical goods. The company is based in Weybridge, UK. Founded in 2012.

Drugstore Chains
Haleon UK Capital Plc
Logo Haleon UK Capital Plc

Haleon UK Capital Plc

Regional BanksFinance

Part of Haleon Plc, Haleon UK Capital Plc is a financial intermediation company. Haleon UK Capital Plc is based in Middlesex, UK. The British company was founded in 2021. The CEO is Brian James McNamara.

Regional Banks
GlaxoSmithKline Consumer Healthcare Finance Ltd.
Logo GlaxoSmithKline Consumer Healthcare Finance Ltd.

GlaxoSmithKline Consumer Healthcare Finance Ltd.

Financial ConglomeratesFinance

Founded in 2014, GlaxoSmithKline Consumer Healthcare Finance Ltd. is a British company that provides investment services. Part of GSK Plc, the company is based in Brentford, UK.

Financial Conglomerates
GSK Consumer Healthcare Capital US LLC
Logo GSK Consumer Healthcare Capital US LLC

GSK Consumer Healthcare Capital US LLC

Medical/Nursing ServicesHealth Services

Part of Haleon Plc, Haleon US Capital LLC is a company that provides healthcare services. Haleon US Capital LLC is based in Wilmington, DE.

Medical/Nursing Services
GlaxoSmithKline Consumer Healthcare Holdings Ltd.
Logo GlaxoSmithKline Consumer Healthcare Holdings Ltd.

GlaxoSmithKline Consumer Healthcare Holdings Ltd.

Financial ConglomeratesFinance

Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Holdings Ltd. functions as an investment holding British company. The company is based in Brentford, UK.

Financial Conglomerates
Gsk Consumer Healthcare Capital Nl BV
Logo Gsk Consumer Healthcare Capital Nl BV

Gsk Consumer Healthcare Capital Nl BV

Pharmaceuticals: OtherHealth Technology

Part of Haleon Plc, Haleon Netherlands Capital BV is a British company that manufactures medicinal and botanicals. The company is located in the UK.

Pharmaceuticals: Other
GlaxoSmithKline Consumer Healthcare (Overseas) Ltd.
Logo GlaxoSmithKline Consumer Healthcare (Overseas) Ltd.

GlaxoSmithKline Consumer Healthcare (Overseas) Ltd.

Financial ConglomeratesFinance

Part of GSK Plc, GlaxoSmithKline Consumer Healthcare (Overseas) Ltd. is a British company that offers Voltarol patches and plasters for effective pain relief. The company is based in Brentford, UK. The text from the 'description' mentions that Voltarol offers different kinds of patches and plasters for pain relief and provides information on common causes of foot and ankle pain. The company was founded in 2014.

Financial Conglomerates

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Haleon plc

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
3.29 GBP
Average target price
3.62 GBP
Spread / Average Target
+10.03%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.09% 693B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 584B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.34% 372B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+7.39% 294B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 211B
NOVARTIS AG Stock Novartis AG
+10.02% 210B
AMGEN INC. Stock Amgen Inc.
+8.49% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. HLN Stock
  4. HLN Stock
  5. Company Haleon plc
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW